Current stage-Stage IV - Page 8 of 9 Posts on Medivizor
Navigation Menu

Current stage-Stage IV Posts on Medivizor

Treating rectal cancer that has spread to the liver: liver or rectum first?

Posted by on Apr 20, 2015 in Colorectal cancer | 0 comments

In a nutshell This study assessed the outcome of a reverse treatment strategy for rectal cancer patients with cancer that has spread to the liver (liver metastases). Some background The best treatment approach for patients with rectal cancer that has spread to the liver is not clear. In some cases the rectal cancer is treated first, followed...

Read More

Maintenance therapy does not impair subsequent treatment with pemetrexed in metastatic lung cancer

Posted by on Feb 23, 2015 in Lung cancer | 0 comments

In a nutshell The authors aimed to determine whether previous maintenance therapy with gemcitabine or erlotinib impaired pemetrexed treatment.  Some background Maintenance therapy is the ongoing use of chemotherapy  or another treatment given to help the primary treatment succeed and prevent cancer recurrence. Two drugs have been...

Read More

Comparing outcomes for patients with EGFR mutations: New drug (afatinib) vs standard therapy

Posted by on Nov 27, 2014 in Lung cancer | 0 comments

In a nutshell This study compared the outcomes between the standard chemotherapy treatment for advanced non-small-cell lung cancer and a new drug, afatinib (Gilotrif, Giotrif) in Asian populations.  Some background Non-small-cell lung cancer (NSCLC) is a common type of lung cancer but can be difficult to treat. Standard treatment involves...

Read More

What treatment is suitable for HER2 positive breast cancer that has spread to the brain?

Posted by on Nov 1, 2014 in Breast cancer | 0 comments

In a nutshell This paper studied methods of treatment in breast cancer brain metastasis.  Some background Breast cancer brain metastasis is cancer that has spread from the breast to the brain and is associated with poor prognosis (outlook). The overexpression of human epidermal growth factor receptor 2 (HER2, a protein on cells)...

Read More

Long-term outcomes following surgery for retroperitoneal recurrence of colorectal cancer

Posted by on Jun 23, 2014 in Colorectal cancer | 0 comments

In a nutshell The authors evaluated the long-term outcomes of patients undergoing surgical resection for retroperitoneal recurrence of colorectal cancer. Some background Patients who undergo curative resection (surgical removal of the cancer) for primary colorectal cancer have a 30–50% chance of disease recurrence (return of the disease)....

Read More

Do circulating tumor cell markers of have both prognostic and predictive values?

Posted by on May 18, 2014 in Colorectal cancer | 0 comments

In a nutshell This study evaluated markers of circulating tumor cells as prognostic factors and predictive factors in patients with metastatic colorectal cancer. Some background Metastatic colorectal cancer (mCRC) is cancer whereby tumor cells have spread from the colon or rectum to other organs and tissues. The cells that escape from...

Read More

Surgical treatment for abdominal melanoma metastases

Posted by on May 1, 2014 in Melanoma | 0 comments

In a nutshell This study evaluated the effectiveness of surgery to remove abdominal melanoma metastatic lesions. In addition, the study proposes a new method of predicting surgery outcomes. Some background Melanoma is a type of malignant skin cancer which has a high tendency to metastasize (spread into distant organs). While patients with...

Read More

Treating unresectable liver metastasis

Posted by on Sep 15, 2013 in Colorectal cancer | 0 comments

In a nutshell This study investigated the combination of hepatic artery infusion (HAI) and systemic chemotherapy for the treatment of unresectable colorectal cancer liver metastasis (CRLM). Some background The liver is the most common site of metastasis (cancer spread) in colorectal cancer patients. Surgical treatments that remove all liver tumors...

Read More

Obesity does not influence outcomes in patients treated for appendix and colon cancer that has spread to the abdominal cavity

Posted by on Aug 8, 2013 in Colorectal cancer | 0 comments

In a nutshell This study evaluated whether obesity has any influence on survival in patients with peritoneal surface disease from colon or appendix cancers undergoing hyperthermic intraperitoneal chemotherapy after cytoreductive surgery. Some background Peritoneal surface disease (PSD) is a condition where cancer has spread to many spots on the...

Read More